News & Updates

Show Multimedia Only

19-year HK data: No causal link between maternal psychotropic exposure and obstetric complications

26 Sep 2025 by

Broad-class psychotropic exposure during pregnancy is not associated with an increased risk of obstetric or neonatal complications, although certain subclasses may carry higher risks, according to a 19-year population-based study in Hong Kong.

19-year HK data: No causal link between maternal psychotropic exposure and obstetric complications

26 Sep 2025

Marital failure linked to subsequent heart failure

26 Sep 2025

Experiencing a loss of stable spousal relationships, particularly recent marital failure, appears to increase susceptibility to heart failure, according to a large study.

Marital failure linked to subsequent heart failure

26 Sep 2025

ESC 2025: Semaglutide outperforms comparator in reducing cardiovascular events

26 Sep 2025

At the recent European Society of Cardiology (ESC) Congress 2025, researchers presented new real-world data comparing semaglutide to tirzepatide. The data demonstrated that semaglutide was more effective than tirzepatide in reducing cardiovascular (CV) events in adults with obesity and established atherosclerotic cardiovascular disease (ASCVD) but without diabetes. The analysis, called STEER, provides the first direct comparative evidence of CV outcomes between the two obesity treatment drugs.

ESC 2025: Semaglutide outperforms comparator in reducing cardiovascular events

26 Sep 2025

Nicotinamide delivers for skin cancer prevention

25 Sep 2025 by

Treatment with the over-the-counter vitamin B3 derivative nicotinamide can lower the risk of new skin cancers, and this risk reduction is greater for cutaneous squamous cell carcinoma and when treatment is initiated after the first skin cancer, according to a large retrospective study.

Nicotinamide delivers for skin cancer prevention

25 Sep 2025

Shortened apixaban therapy ups bleeding in VTE patients

25 Sep 2025

Patients treated with shortened lead-in apixaban for venous thromboembolism (VTE) show increased bleeding events, and those with bleeding risk factors appear to gain no benefit from taking apixaban 10 mg twice daily, according to a study.

Shortened apixaban therapy ups bleeding in VTE patients

25 Sep 2025

Long-term bimekizumab delivers durable efficacy in plaque psoriasis

25 Sep 2025 by

Treatment with bimekizumab for 4 years results in satisfactory levels of clinical and health-related quality of life responses, reports a study. The majority of patients with moderate-to-severe plaque psoriasis achieve near-complete skin clearance, while nearly two-thirds have complete skin clearance.

Long-term bimekizumab delivers durable efficacy in plaque psoriasis

25 Sep 2025

Is it safe to use high-dose PTZ in critically ill patients with obesity?

25 Sep 2025

High piperacillin-tazobactam (PTZ) dosing does not lead to increased acute nephrotoxicity, thrombocytopenia, 14-day all-cause mortality, or intensive care unit (ICU) length of stay (LOS), suggests a recent study.

Is it safe to use high-dose PTZ in critically ill patients with obesity?

25 Sep 2025

Bariatric surgery more effective, affordable than GLP-1RAs for severe obesity

25 Sep 2025

For individuals with class II and III obesity, metabolic bariatric surgery appears to result in durable weight loss at lower ongoing costs when compared with glucagon-like peptide-1 receptor agonists (GLP-1RAs), according to a study.

Bariatric surgery more effective, affordable than GLP-1RAs for severe obesity

25 Sep 2025

Menopausal hormone therapy poses cardiac risk for older women

24 Sep 2025 by

Hormone therapy for vasomotor symptoms (VMS) appears to raise the risk of atherosclerotic cardiovascular disease (ASCVD) for women exposed to the treatment later in life, according to a secondary analysis of two Women’s Health Initiative (WHI) trials.

Menopausal hormone therapy poses cardiac risk for older women

24 Sep 2025

Personalized risk messages improve CRC screening uptake

24 Sep 2025

A recent study has shown that the inclusion of personalized risk for advanced colorectal neoplasia (ACN) in a decision aid or provider notification provides no overall effect, but it has led to an increase in the uptake of stool testing in one health system.

Personalized risk messages improve CRC screening uptake

24 Sep 2025

News & Updates

Filter by Specialty:

Specialty:

19-year HK data: No causal link between maternal psychotropic exposure and obstetric complications

19-year HK data: No causal link between maternal psychotropic exposure and obstetric complications

Marital failure linked to subsequent heart failure

Marital failure linked to subsequent heart failure

ESC 2025: Semaglutide outperforms comparator in reducing cardiovascular events

ESC 2025: Semaglutide outperforms comparator in reducing cardiovascular events

Nicotinamide delivers for skin cancer prevention

Nicotinamide delivers for skin cancer prevention

Shortened apixaban therapy ups bleeding in VTE patients

Shortened apixaban therapy ups bleeding in VTE patients

Long-term bimekizumab delivers durable efficacy in plaque psoriasis

Long-term bimekizumab delivers durable efficacy in plaque psoriasis

Is it safe to use high-dose PTZ in critically ill patients with obesity?

Is it safe to use high-dose PTZ in critically ill patients with obesity?

Bariatric surgery more effective, affordable than GLP-1RAs for severe obesity

Bariatric surgery more effective, affordable than GLP-1RAs for severe obesity

Menopausal hormone therapy poses cardiac risk for older women

Menopausal hormone therapy poses cardiac risk for older women

Personalized risk messages improve CRC screening uptake

Personalized risk messages improve CRC screening uptake